Recruiting Primary Biliary Cholangitis Studies in South San Francisco
About Primary Biliary Cholangitis Clinical Trials in South San Francisco
Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease in which the bile ducts in the liver are slowly destroyed. This leads to bile buildup, liver damage, and potentially cirrhosis. Treatment includes ursodeoxycholic acid and obeticholic acid.
There are currently 1 primary biliary cholangitis clinical trials recruiting participants in South San Francisco, CA. These studies are seeking a combined 402 participants. Research is being sponsored by Gilead Sciences. Clinical trial participation is free and participants receive study-related medical care at no cost.
Primary Biliary Cholangitis Clinical Trials in South San Francisco — FAQ
Are there primary biliary cholangitis clinical trials in South San Francisco?
Yes, there are 1 primary biliary cholangitis clinical trials currently recruiting in South San Francisco, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in South San Francisco?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the South San Francisco research site will contact you about next steps.
Are clinical trials in South San Francisco free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many South San Francisco studies also compensate for your time and travel.
What primary biliary cholangitis treatments are being tested?
The 1 active trials in South San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for primary biliary cholangitis.
Data updated October 16, 2026 from ClinicalTrials.gov